Discover the latest news from the Pulmonary Hypertension, including advocacy updates, research articles and event coverage.
Open enrollment starts Oct. 15 for Medicare and Nov. 1 for ACA plans. Compare options carefully and avoid non-ACA-regulated coverage.
Insurance & treatment access | News
PH care deserts force many patients to travel far for expert treatment. Dorothy Briggs’ story highlights the need for specialized care.
News
Mark Lung Transplant Awareness Day with free educational resources, patient stories, social media graphics, and a free book download.
News
People with pulmonary hypertension face higher risks from flu and COVID-19. Stay protected by getting recommended vaccines this fall.
News
Sickle Cell and Pulmonary Fibrosis Awareness Month highlights how associated conditions can increase the risk of pulmonary hypertension.
News
Hear from leading PH experts at PHA’s PH Wellness Expo in San Francisco, with exhibits, advocacy sessions and family fun.
Events | News
The label references trial data that shows the drug as safe and effective for moderate to high-risk PAH.
Pulmovant is enrolling participants in its Phase 3 mosliciguat study after positive Phase 2 results.
The FDA will review United Therapeutic’s new drug application for Ralinepag, a once-daily pill to treat PAH.
